Linc AB (STO:LINC)

Sweden flag Sweden · Delayed Price · Currency is SEK
72.50
-0.60 (-0.82%)
May 5, 2026, 5:29 PM CET
Market Cap4.23B +9.7%
Revenue (ttm)437.99M +103.8%
Net Income419.45M +71.7%
EPSn/a
Shares Out57.91M
PE Ratio10.09
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,668
Average Volume43,101
Open73.60
Previous Close73.10
Day's Range71.40 - 74.60
52-Week Range58.90 - 83.60
Beta0.71
RSI47.55
Earnings DateMay 5, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9... [Read more]

Sector Financials
Founded 1991
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol LINC
Full Company Profile

Financial Performance

Financial Statements